检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:谢利剑[1] 马晓静[2] 俞岑妍[2] 黄敏[1] 陈树宝[3] 王荣发[4] 黄美蓉[3] 过仲珍[5] 蒋瑾瑾[6] 周晓迅[7] 于清[8] 邱定忠[9] 黄国英[2]
机构地区:[1]上海交通大学附属儿童医院,上海200040 [2]复旦大学附属儿科医院,上海201102 [3]上海交通大学医学院附属上海儿童医学中心,上海200127 [4]上海交通大学医学院附属新华医院,上海200092 [5]上海交通大学附属第六人民医院,上海200233 [6]第二军医大学附属长海医院,上海200433 [7]同济大学附属同济医院,上海200065 [8]上海交通大学医学院附属仁济医院,上海200001 [9]上海交通大学医学院附属瑞金医院,上海200025
出 处:《临床儿科杂志》2010年第7期624-627,共4页Journal of Clinical Pediatrics
基 金:日本文部省Monbu-Kagakusho研究基金;日本川崎病研究中心基金(No.2003-2004)
摘 要:目的探讨静脉丙种球蛋白(IVIG)的不同治疗方案对川崎病(KD)患儿发生冠状动脉病变(CAL)的影响,提出最佳的IVIG治疗建议方案。方法回顾性分析1998—2007年上海地区住院KD患儿1682例的临床资料,男1064例,女618例;发病年龄0.1~18.8岁,平均(2.57±2.33)岁。其中1533例(91.1%)使用IVIG治疗,方案包括①1g/kg×1次;②2g/kg×1次;③0.4~0.5g/kg×5次;④1g/kg×2次;⑤2g/kg×2次;⑥不规则治疗。IVIG治疗的时间窗包括:①病程1~4d;②病程5~10d;③病程>10d。结果在1533例IVIG治疗的KD患儿中,CAL总发生率为20.74%。与此相比较,CAL发生率明显降低者如下:①在病程5~10d应用IVIG治疗1g/kg×2次的KD患儿,其CAL发生率为12.06%;②病程5~10d应用1g/kg×1次者CAL发生率为15.00%;③病程1~4d应用1g/kg×1次者CAL发生率为16.28%;④病程5~10d应用2g/kg×1次者CAL发生率为16.71%。相反,以下几种情况CAL发生率明显高于CAL总发生率:①在病程10d以上应用IVIG者;②使用IVIG2g/kg×2次(因使用1次后效果不佳而再次使用);③其他不规律使用IVIG者。结论在IVIG治疗KD、减少CAL方面,以病程5~10d使用IVIG1g/kg×2次效果最佳;但考虑经济因素和大剂量IVIG潜在的风险,在病程10d以内使用IVIG1g/kg×1次亦是不错的选择。Objective To evaluate the impacts of different regimens of intravenous immunoglobulin (IVIG) on the coronary artery lesion (CAL) in children with Kawasaki disease (KD). Methods 1 682 inpatients of KD from 1998 through 2007 in Shanghai were recruited with 1 064 males and 618 females, aged 2.57 ± 2.33 years (0.1 - 18.8 years). In total cases, there were 1 533 cases (91.1%) with IVIG. There were six different regimens of IVIG, which were 1 g/kg, once; 2 g/kg, once; 0.4- 0.5 g/kg, five times; 1 g/kg, twice; 2 g/kg, twice; and others. The therapeutic windows were within 4 days, from the fifth day to the tenth day, and after 10 days, respectively. Results In a total of 1 533 cases with IVIG, the incidence of CAL was 20.74%. Comparatively, the incidence was lower in patients with following regimens of IVIG: (1) IVIG 1 g/kg twice from the fifth day to the tenth day (the ineidence of CAL was 12.06%) ; (2) IVIG 1 g/kg once from the fifth day to the tenth day (the incidence of CAL was 15.00%) ; (3) IVIG 1 g/kg once within 4 days (the incidence of CAL was 16.28%) ; (4) IVIG 2 g/kg once from the fifth day to the tenth day (The incidence of CAL was 16.71%). Conversely, the incidence of CAL was higher in patients with the following regimens of IVIG: (1) IVIG after 10 days; (2) IVIG 2 g/kg twice (reused for unfavorable effect); (3) IGIV others. Conclusions The regimen of IVIG 1 g/kg twice from the fifth day to the tenth day is recommended in children with KD. Taken into consideration of the cost-eflectiveness and risks of huge dosage of IVIG, IV1G 1 g/kg once within 10 days should be an alternative choice.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.188